Kazhybek Moshkal

Dr. Kazhybek Moshkal

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
KMKazhybek Moshkal
Kazhybek Moshkal
Saken KhaidarovSaken Khaidarov
Saken Khaidarov
NJNurlan T. Jainakbayev
Nurlan T. Jainakbayev
VMValentin M. Madyarov
Valentin M. Madyarov
NDNurlan Duisenov
Nurlan Duisenov
Mukhit KulmaganbetovMukhit Kulmaganbetov
Mukhit Kulmaganbetov
Background: Fascial healing depends on type I collagen, yet collagen metabolism is rarely considered when choosing an abdominal wall closure technique. Objective: to describe the early incidence of postoperative ventral hernia (PVH) after closure stratified by preoperative collagen biomarkers and combined with subaponeurotic platelet-rich plasma (PRP). Methods: Prospective single-centre cohort of 106 consecutive adults (October 2024–December 2025) undergoing elective hernia repair (n = 61) or other abdominal surgery (n = 45). Serum P1NP and CTX-I defined low (n = 35), moderate (n = 27) and high (n = 44) collagen groups. Mesh was used in all low-collagen patients, in 12 moderate-collagen patients and in no high-collagen patients; all patients received PRP. Incidence was reported with Wilson 95% confidence intervals (CIs); groups were compared with exact tests, Welch’s ANOVA and multinomial regression. Results: One PVH occurred (0.9%; 95% CI 0.2–5.2%), a recurrence after mesh repair in the low-collagen group. Upper confidence limits were 12.5% and 8.0% in the moderate- and high-collagen groups. Lower collagen category was associated with older age (OR for high vs. low 0.30 per 10 years; 95% CI 0.18–0.52) and with cardiovascular comorbidity. There were no deep infections, mesh removals or deaths. Conclusions: The protocol was feasible and early PVH was rare. Because every patient received PRP, mesh use followed the collagen group and follow-up was short, these data cannot show that either component prevents PVH; a randomised trial is needed.

31 December 2024 in BULLETIN OF SURGERY IN KAZAKHSTAN
Verified
Journal Article
Closed access
KMKazhybek Moshkal
Kazhybek Moshkal
JNJainakbayev N
Jainakbayev N
MVMadyarov V
Madyarov V
Background. At the current stage of surgical development, the problem of prevention of postoperative ventral hernias after abdominal surgeries remains unsolved. The research aims to identify the most effective approaches to the prevention of postoperative ventral hernias and to improve surgical treatment outcomes. Methods. A systematic analysis of existing publications, scientific articles, and clinical guidelines focused on the prevention and treatment of postoperative ventral hernias after abdominal surgeries will be conducted. Special attention will be paid to studies describing various surgical plastic techniques and the application of biological materials. Results. To systematize existing methods for the prevention and treatment of postoperative ventral hernias by analyzing their effectiveness and safety. To identify the most suitable surgical techniques and materials that reduce the risk of developing postoperative ventral hernias. To highlight the need for further research in the application of biological materials and new technologies in the prevention and treatment of postoperative ventral hernias. Conclusion. New technologies and materials, such as biocompatible meshes and antimicrobial sutures, have the potential to enhance treatment outcomes. However, systematic and standardized prevention and diagnostic methods are essential for equipping surgeons to mitigate postoperative ventral hernias risk. Research on collagen status, its various types in connective tissue, and new diagnostic methods will be crucial for improving patient quality of life and reducing surgical risks.